WellAlly Logo
WellAlly康心伴
Back to Biomarkers
Cardiology

NT-proBNP: The Heart Failure Biomarker

NT-proBNP is released when the heart muscle is stretched or stressed. It's the primary biomarker for diagnosing and managing heart failure, and elevated levels indicate significant cardiovascular stress even without symptoms.

Reference: < 125 pg/mL (< 75 years), < 450 pg/mL (75+ years) - varies by lab and age pg/mL

Key Takeaway

NT-proBNP is like a distress signal from your heart. When heart muscle cells are stretched (from pressure or volume overload), they release NT-proBNPJanuzzi JL, et al. 2021. The higher the level, the more stressed your heart. Levels are incredibly useful for ruling in or ruling out heart failure.

What is NT-proBNP?

N-terminal pro b-type natriuretic peptide (NT-proBNP) is a biomarker released by heart muscle cells in response to stretch and stress. It's produced along with BNP when the heart is working harder than normal—typically from heart failure, but also from other causes of cardiac strain.

Think of NT-proBNP as your heart's cry for help. When the heart is struggling to pump blood against increased pressure or volume, it releases this hormone, which helps the body eliminate excess fluid and lower blood pressure.

Why NT-proBNP Matters

  • Heart failure diagnosis: Highly sensitive and specificMaisel AS, et al. 2021
  • Rule-out tool: Very low levels effectively exclude heart failureJanuzzi JL, et al. 2021
  • Prognosis: Higher levels = worse outcomesNakamura M, et al. 2020
  • Monitoring: Levels track disease progression and response to treatment
  • Silent detection: Can identify cardiac stress before symptoms develop

Rule-out thresholds (values below effectively exclude heart failure):

Januzzi JL, et al. 2021

  • Under 50 years: ＜ 300 pg/mL
  • 50-75 years: ＜ 450 pg/mL
  • Over 75 years: ＜ 900 pg/mL

Diagnostic thresholds (values above suggest heart failure):

  • Any age: > 900 pg/mL strongly suggests heart failure
  • "Gray zone": 300-900 pg/mL requires clinical correlation

Note: Reference ranges vary by laboratory. Always use your lab's specific ranges.

Interpreting Your Level

Understanding Your Results (pg/mL)

Normal
＜ 125 (＜75 yrs) or ＜ 450 (75+ yrs)

No evidence of heart failure. Heart muscle not significantly stressed.

Gray Zone
125-900 (varies by age)

Possible cardiac stress. May indicate early heart failure or other causes. Correlate with symptoms and imaging.

Elevated
> 900

Strongly suggests heart failure or significant cardiac stress. Cardiology evaluation recommended.<Citation>Ponikowski P, et al. 2021</Citation>

Kidney Disease Complicates Interpretation

NT-proBNP is cleared by the kidneys. In kidney disease, levels rise even without heart failureNKF, 2021. For interpretation, use higher age- and kidney-adjusted thresholds. The cardiology community has developed specific cutoffs for CKD patients. If you have kidney disease, work with a specialist familiar with these adjustments.

NT-proBNP vs BNP

Both are released together but have key differencesAHA, 2020:

| Feature | NT-proBNP | BNP | |---------|-----------|-----| | Half-life | 1-2 hours (longer) | 20 minutes (shorter) | | Stability | Very stable | Less stable | | Kidney dependence | More affected | Less affected | | Clinical use | Chronic monitoring preferred | Acute setting preferred |

Both are excellent diagnostic tests. Most labs now offer NT-proBNP due to superior stability.

Clinical Applications

1. Diagnosing Heart FailureMcMurray JJ, et al. 2022

  • Differentiating cardiac vs pulmonary causes of shortness of breath
  • Screening for asymptomatic left ventricular dysfunction
  • Very sensitive—can detect early heart disease

2. PrognosisNakamura M, et al. 2020

  • Higher levels predict higher mortality
  • Useful for risk stratification
  • Guides intensity of treatment

3. Monitoring

  • Levels should decrease with effective heart failure treatment
  • Rising levels signal worsening condition
  • Guides medication titration

What to Do If Elevated

If NT-proBNP is elevated without known heart failureCDC, 2022:

  1. Echocardiogram: Assess heart structure and pumping function
  2. Cardiology consultation: Specialist evaluation
  3. Review medications: Some drugs affect levels
  4. Screen for causes: Is there valve disease, arrhythmia, or coronary disease?
  5. Optimize risk factors: Blood pressure, weight, diabetes control

Related Testing

  • hs-Troponin: Heart muscle damage marker
  • [Echocardiogram]: Imaging to assess heart structure and function
  • [BNP]: Alternative heart failure marker

FAQ

Track Your Health Journey

Monitor your biomarkers over time to understand your health trends.

NT-proBNP: The Heart Failure Biomarker | Biomarker Guide